Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Tadalafil NDC 71610-353 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a chart or table displaying blood pressure readings with the medications Tacalafi and Doxazosin being administered in different scenarios, with time post-dose being a factor. However, the chart is somewhat incomplete and without further context it is difficult to provide a more complete useful description.*
This text seems to show information related to the measurement of Systolic Blood Pressure (BP) at different times after the administration of different doses of drugs, including Tacalaf and Doxazosin. However, the text is incomplete and does not provide sufficient context to interpret the information fully. Therefore, it may not be useful for a reader without additional information.*
This is a graph showing the plasma concentration of Tadalafil at different time points (in hours) after administering different doses. The doses include a single 20 mg dose, a single 5 mg dose, and a once-daily 5 mg dose for 5 consecutive days. The concentration of Tadalafil is measured in mcg/mL, with values ranging from 0 to 400.*
This appears to be a table or graph showing the comparison of Tadalafil 5mg and Placebo with respect to the PSS Total Score over a period of 8 to 12 weeks of treatment. No further information can be deduced from the given text.*
This appears to be a graph or table showing the LS Mean Change from Baseline over 12 and 26 weeks of therapy for TadalafilFinasteride compared to Placebo/Finasteride, with a line indicating the Least-Squares Treatment Difference. Without further context or information, it is difficult to provide a more precise or useful description.*
The text describes the change in the IPSS total score for patients receiving Tadalafil 5mg compared to the placebo. The change is statistically significant (p<0.01). The duration of treatment is not provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.